![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PEX19 |
Gene summary for PEX19 |
![]() |
Gene information | Species | Human | Gene symbol | PEX19 | Gene ID | 5824 |
Gene name | peroxisomal biogenesis factor 19 | |
Gene Alias | D1S2223E | |
Cytomap | 1q23.2 | |
Gene Type | protein-coding | GO ID | GO:0006457 | UniProtAcc | P40855 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
5824 | PEX19 | P56T-E | Human | Esophagus | ESCC | 6.51e-12 | 1.16e+00 | 0.1613 |
5824 | PEX19 | P57T-E | Human | Esophagus | ESCC | 1.18e-16 | 3.21e-01 | 0.0926 |
5824 | PEX19 | P61T-E | Human | Esophagus | ESCC | 2.40e-11 | 3.08e-01 | 0.099 |
5824 | PEX19 | P62T-E | Human | Esophagus | ESCC | 7.91e-27 | 4.27e-01 | 0.1302 |
5824 | PEX19 | P65T-E | Human | Esophagus | ESCC | 4.42e-12 | 2.41e-01 | 0.0978 |
5824 | PEX19 | P74T-E | Human | Esophagus | ESCC | 5.04e-18 | 4.88e-01 | 0.1479 |
5824 | PEX19 | P75T-E | Human | Esophagus | ESCC | 4.64e-22 | 4.80e-01 | 0.1125 |
5824 | PEX19 | P76T-E | Human | Esophagus | ESCC | 6.22e-35 | 5.58e-01 | 0.1207 |
5824 | PEX19 | P79T-E | Human | Esophagus | ESCC | 3.25e-25 | 4.48e-01 | 0.1154 |
5824 | PEX19 | P80T-E | Human | Esophagus | ESCC | 7.76e-22 | 6.07e-01 | 0.155 |
5824 | PEX19 | P82T-E | Human | Esophagus | ESCC | 1.96e-07 | 5.34e-01 | 0.1072 |
5824 | PEX19 | P83T-E | Human | Esophagus | ESCC | 4.15e-27 | 6.89e-01 | 0.1738 |
5824 | PEX19 | P89T-E | Human | Esophagus | ESCC | 3.35e-14 | 7.83e-01 | 0.1752 |
5824 | PEX19 | P91T-E | Human | Esophagus | ESCC | 9.76e-12 | 9.15e-01 | 0.1828 |
5824 | PEX19 | P104T-E | Human | Esophagus | ESCC | 1.25e-02 | 2.77e-01 | 0.0931 |
5824 | PEX19 | P107T-E | Human | Esophagus | ESCC | 7.84e-38 | 8.20e-01 | 0.171 |
5824 | PEX19 | P126T-E | Human | Esophagus | ESCC | 3.31e-02 | 3.94e-01 | 0.1125 |
5824 | PEX19 | P127T-E | Human | Esophagus | ESCC | 2.14e-11 | 2.10e-01 | 0.0826 |
5824 | PEX19 | P128T-E | Human | Esophagus | ESCC | 2.56e-19 | 6.26e-01 | 0.1241 |
5824 | PEX19 | P130T-E | Human | Esophagus | ESCC | 1.99e-50 | 9.97e-01 | 0.1676 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0072594110 | Esophagus | ESCC | establishment of protein localization to organelle | 311/8552 | 422/18723 | 3.02e-32 | 2.13e-29 | 311 |
GO:0031647111 | Esophagus | ESCC | regulation of protein stability | 223/8552 | 298/18723 | 5.76e-25 | 1.52e-22 | 223 |
GO:0006605111 | Esophagus | ESCC | protein targeting | 229/8552 | 314/18723 | 4.93e-23 | 1.01e-20 | 229 |
GO:0006457110 | Esophagus | ESCC | protein folding | 163/8552 | 212/18723 | 1.13e-20 | 1.74e-18 | 163 |
GO:0051098111 | Esophagus | ESCC | regulation of binding | 251/8552 | 363/18723 | 6.73e-20 | 8.46e-18 | 251 |
GO:0090150110 | Esophagus | ESCC | establishment of protein localization to membrane | 182/8552 | 260/18723 | 1.27e-15 | 8.19e-14 | 182 |
GO:001703818 | Esophagus | ESCC | protein import | 149/8552 | 206/18723 | 5.90e-15 | 3.31e-13 | 149 |
GO:0050821111 | Esophagus | ESCC | protein stabilization | 140/8552 | 191/18723 | 6.50e-15 | 3.61e-13 | 140 |
GO:00482853 | Esophagus | ESCC | organelle fission | 301/8552 | 488/18723 | 4.64e-13 | 2.12e-11 | 301 |
GO:0061077110 | Esophagus | ESCC | chaperone-mediated protein folding | 56/8552 | 67/18723 | 1.52e-10 | 4.36e-09 | 56 |
GO:0051100111 | Esophagus | ESCC | negative regulation of binding | 109/8552 | 162/18723 | 2.10e-08 | 4.03e-07 | 109 |
GO:00066124 | Esophagus | ESCC | protein targeting to membrane | 83/8552 | 131/18723 | 3.31e-05 | 2.73e-04 | 83 |
GO:00066252 | Esophagus | ESCC | protein targeting to peroxisome | 14/8552 | 18/18723 | 5.77e-03 | 2.14e-02 | 14 |
GO:00726622 | Esophagus | ESCC | protein localization to peroxisome | 14/8552 | 18/18723 | 5.77e-03 | 2.14e-02 | 14 |
GO:00726632 | Esophagus | ESCC | establishment of protein localization to peroxisome | 14/8552 | 18/18723 | 5.77e-03 | 2.14e-02 | 14 |
GO:00435742 | Esophagus | ESCC | peroxisomal transport | 16/8552 | 22/18723 | 9.46e-03 | 3.28e-02 | 16 |
GO:00064577 | Liver | Cirrhotic | protein folding | 114/4634 | 212/18723 | 9.23e-20 | 2.31e-17 | 114 |
GO:007259412 | Liver | Cirrhotic | establishment of protein localization to organelle | 189/4634 | 422/18723 | 1.01e-19 | 2.45e-17 | 189 |
GO:003164712 | Liver | Cirrhotic | regulation of protein stability | 144/4634 | 298/18723 | 6.74e-19 | 1.28e-16 | 144 |
GO:00066057 | Liver | Cirrhotic | protein targeting | 148/4634 | 314/18723 | 3.86e-18 | 6.20e-16 | 148 |
Page: 1 2 3 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa041467 | Esophagus | ESCC | Peroxisome | 55/4205 | 82/8465 | 1.04e-03 | 3.27e-03 | 1.68e-03 | 55 |
hsa0414612 | Esophagus | ESCC | Peroxisome | 55/4205 | 82/8465 | 1.04e-03 | 3.27e-03 | 1.68e-03 | 55 |
hsa041462 | Liver | Cirrhotic | Peroxisome | 36/2530 | 82/8465 | 4.79e-03 | 1.74e-02 | 1.07e-02 | 36 |
hsa041463 | Liver | Cirrhotic | Peroxisome | 36/2530 | 82/8465 | 4.79e-03 | 1.74e-02 | 1.07e-02 | 36 |
hsa041464 | Liver | HCC | Peroxisome | 58/4020 | 82/8465 | 1.57e-05 | 1.05e-04 | 5.85e-05 | 58 |
hsa041465 | Liver | HCC | Peroxisome | 58/4020 | 82/8465 | 1.57e-05 | 1.05e-04 | 5.85e-05 | 58 |
hsa041466 | Oral cavity | OSCC | Peroxisome | 47/3704 | 82/8465 | 9.01e-03 | 2.01e-02 | 1.03e-02 | 47 |
hsa0414611 | Oral cavity | OSCC | Peroxisome | 47/3704 | 82/8465 | 9.01e-03 | 2.01e-02 | 1.03e-02 | 47 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PEX19 | SNV | Missense_Mutation | c.526C>G | p.Gln176Glu | p.Q176E | P40855 | protein_coding | tolerated(0.09) | possibly_damaging(0.83) | TCGA-AO-A0J3-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | cyclophosphamide | SD | |
PEX19 | SNV | Missense_Mutation | c.463N>G | p.Lys155Glu | p.K155E | P40855 | protein_coding | deleterious(0.01) | possibly_damaging(0.764) | TCGA-AO-A0JE-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicin | SD | |
PEX19 | SNV | Missense_Mutation | novel | c.280N>G | p.Leu94Val | p.L94V | P40855 | protein_coding | tolerated(0.09) | probably_damaging(0.953) | TCGA-D8-A1JP-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | tamoxiphen | SD |
PEX19 | SNV | Missense_Mutation | rs868021380 | c.37N>A | p.Glu13Lys | p.E13K | P40855 | protein_coding | tolerated_low_confidence(0.33) | benign(0.024) | TCGA-MY-A5BF-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Chemotherapy | cisplatin | CR |
PEX19 | SNV | Missense_Mutation | c.698N>T | p.Glu233Val | p.E233V | P40855 | protein_coding | deleterious(0) | probably_damaging(0.983) | TCGA-AZ-6608-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
PEX19 | SNV | Missense_Mutation | rs749320010 | c.651A>C | p.Lys217Asn | p.K217N | P40855 | protein_coding | deleterious(0.01) | benign(0.19) | TCGA-AG-3892-01 | Colorectum | rectum adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PEX19 | SNV | Missense_Mutation | rs149976198 | c.857N>T | p.Ser286Leu | p.S286L | P40855 | protein_coding | deleterious(0.02) | benign(0.143) | TCGA-AP-A1DV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PEX19 | SNV | Missense_Mutation | rs560911616 | c.20G>A | p.Gly7Asp | p.G7D | P40855 | protein_coding | tolerated_low_confidence(1) | benign(0) | TCGA-B5-A11E-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PEX19 | SNV | Missense_Mutation | c.614G>T | p.Ser205Ile | p.S205I | P40855 | protein_coding | tolerated(0.17) | benign(0.022) | TCGA-B5-A1MX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Hormone Therapy | megace | SD | |
PEX19 | SNV | Missense_Mutation | c.649N>C | p.Lys217Gln | p.K217Q | P40855 | protein_coding | deleterious(0.01) | benign(0.388) | TCGA-BS-A0UJ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |